A Tau Vaccine for Alzheimer’s?: A Conversation With Norbert Žilka
While some scientists are focused on targeting beta-amyloid plaques to treat Alzheimer's, others are honing in on another hallmark of the disease — pathological tau proteins — and developing a tau vaccine in hopes of preventing the disease. Being Patient… More
Gut Microbes and Alzheimer’s: A Conversation With Barbara Bendlin
In a new field of research, scientists are studying whether microorganisms in the gut may influence brain health and Alzheimer's. Researchers have found that not only do people with Alzheimer's have altered gut microbiomes, but bacteria in their gut is… More
Down Syndrome and Alzheimer’s: A Conversation with Dr. Brian Skotko
People with Down syndrome are more likely to develop Alzheimer’s disease than the general population. Scientists believe that studying Down syndrome may offer vital clues to in the quest to develop effective treatments for Alzheimer’s. Being Patient spoke with Dr.… More
Epigenetics and Alzheimer’s: A Conversation with Raffaella Nativio
Alzheimer's main hallmarks — beta-amyloid plaques and tau tangles — have long been the focus of the quest to come up with an Alzheimer's drug. However, clinical trials for drugs that focus on these hallmarks have largely failed. Increasingly, scientists… More
Palliative Care and Dementia: A Conversation With Dr. Erin Zahradnik
A dementia diagnosis may upend life plans for both the person with the diagnosis and their family. Dr. Erin Zahradnik, who provides palliative care for people living with dementia, offers a few tips for those who are learning to be… More